Sanofi Ventures
Investor profile
CorporateVenture capital
Also recorded as: Sanofi
Deals
11
distinct rounds
Companies
10
backed
Active span
2020–2025
6 yrs
Total round €
€792M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Adjuvant Capital2
- Asabys Partners2
- EQT Life Sciences2
- Industrifonden2
- LF Investment2
- Novo Holdings2
- Sunstone Life Science Ventures2
- Trill Impact Ventures2
- Wellington Partners2
- Bpifrance1
- CMA CGM Ventures1
- Gilde Healthcare1
- GV1
- Invus1
- Khosla Ventures1
- New Enterprise Associates1
- Northpond Ventures1
- Novartis Venture Fund1
- OrbiMed1
- Oxford Science Enterprises1
- Oxford University Innovation Fund1
- Pureos Bioventures1
- Pureos Ventures1
- Repair Impact Fund1
- Roche Venture Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Owkin | France | 1 | €159M |
| Aqemia | France | 1 | €130M |
| SpliceBio | Spain | 1 | €118M |
| OMass Therapeutics | UK | 1 | €90M |
| Agomab Therapeutics | Belgium | 1 | €83M |
| MinervaX | Denmark | 2 | €76M |
| Lava Therapeutics | Netherlands | 1 | €70M |
| Gyroscope Therapeutics | UK | 1 | €35M |
| Eligo Bioscience | France | 1 | €28M |
| Livmed’s | France | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Owkin | Other | €159M | 2021-11 |
| Aqemia | Other | €130M | 2023-12 |
| SpliceBio | Series B | €118M | 2025-06 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Lava Therapeutics | Series C | €70M | 2020-09 |
| MinervaX | Other | €54M | 2023-10 |
| Gyroscope Therapeutics | Other | €35M | 2021-11 |
| Eligo Bioscience | Series B | €28M | 2023-12 |
| MinervaX | Other | €22M | 2022-12 |